Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
159
NCT05733299
Aflo™ Device Trial
Phase: N/A
Role: Collaborator
Start: Feb 6, 2023
Completion: Feb 5, 2024
NCT06991023
Prebiotic Effects on Anxiety, Cortisol, and Emotional Processing in Mild-to-Moderately Stressed Adults
Start: Mar 31, 2025
Completion: Dec 31, 2025